相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Sheng-Xiao Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update
Ping-Min Chen et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
Melissa E. Munroe et al.
FRONTIERS IN IMMUNOLOGY (2021)
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
Nicholas L. Li et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus
Jenny H. Xie et al.
JOURNAL OF IMMUNOLOGY (2021)
Global epidemiology of systemic lupus erythematosus
Megan R. W. Barber et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Baricitinib Attenuates Autoimmune Phenotype and Podocyte Injury in a Murine Model of Systemic Lupus Erythematosus
Jaeseon Lee et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
Feliciano Chanana Paquissi et al.
FRONTIERS IN MEDICINE (2021)
Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
Tianbiao Zhou et al.
STEM CELLS INTERNATIONAL (2020)
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
William Camu et al.
EBIOMEDICINE (2020)
Harnessing Endogenous T-Regulatory Cells in Acute Kidney Injury
Rahul Sharma
NEPHRON (2020)
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice
Fatin Nurizzati Mohd Jaya et al.
CELLS (2020)
Prediction of molecular mimicry between antigens from Leishmania sp. and human: Implications for autoimmune response in systemic lupus erythematosus
M. Munera et al.
MICROBIAL PATHOGENESIS (2020)
The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2
Jia Wang et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification
Zhenhuan Zhao et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Dysregulation of T Follicular Helper Cells in Lupus
John D. Mountz et al.
JOURNAL OF IMMUNOLOGY (2019)
IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent
Marta E. Stremska et al.
JOURNAL OF AUTOIMMUNITY (2019)
Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients
Yamei Tang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity
Julia Hagenstein et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients
Chunmiao Zhao et al.
BMC IMMUNOLOGY (2019)
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjogren's syndrome
Miao Miao et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis
Tiong Y. Lim et al.
HEPATOLOGY (2018)
Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury
Marina Gazdic et al.
LIVER TRANSPLANTATION (2018)
Foxp3+ T Regulatory Cells: Still Many Unanswered Questions-A Perspective After 20 Years of Study
Ethan M. Shevach
FRONTIERS IN IMMUNOLOGY (2018)
Regulatory T cells in acute and chronic kidney diseases
Rahul Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
The role and therapeutic targeting of IL-6 in rheumatoid arthritis
Masashi Narazaki et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice
Jonathan Sitrin et al.
JOURNAL OF IMMUNOLOGY (2017)
IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury
Marta E. Stremska et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
Tobias Schmid et al.
FRONTIERS IN IMMUNOLOGY (2017)
Role of interferons in SLE
Anders A. Bengtsson et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
RORγt+Foxp3+ Cells are an Independent Bifunctional Regulatory T Cell Lineage and Mediate Crescentic GN
Malte A. Kluger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Foxp3+ T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation
B-H Yang et al.
MUCOSAL IMMUNOLOGY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium
Jozsef Prechl et al.
PLOS ONE (2016)
Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients
Patricia Lopez et al.
SCIENTIFIC REPORTS (2016)
ST2 and Patient Prognosis in Chronic Heart Failure
Antoni Bayes-Genis et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Soluble ST2-Analytical Considerations
Thomas Mueller et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
ST2 in Pulmonary Disease
Ednan K. Bajwa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
The microbiota regulates type 2 immunity through RORγt+ T cells
Caspar Ohnmacht et al.
SCIENCE (2015)
Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells
Esen Sefik et al.
SCIENCE (2015)
IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice
Pin Li et al.
INFLAMMATION (2014)
IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells
Benjamin M. Matta et al.
JOURNAL OF IMMUNOLOGY (2014)
T cell-intrinsic role of IL-6 signaling in primary and memory responses
Simone A. Nish et al.
ELIFE (2014)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease
Derek E. Byers et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis
Yan Ge et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Blockade of Programmed Death-1 in Young (New Zealand Black x New Zealand White)F1 Mice Promotes the Suppressive Capacity of CD4+ Regulatory T Cells Protecting from Lupus-like Disease
Maida Wong et al.
JOURNAL OF IMMUNOLOGY (2013)
Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1
Chauncey J. Spooner et al.
NATURE IMMUNOLOGY (2013)
Interleukin-6: a new therapeutic target in systemic sclerosis?
Steven O'Reilly et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2013)
IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation
Shyr-Te Ju et al.
CLINICAL IMMUNOLOGY (2012)
IL-33/ST2 axis in inflammation and immunopathology
Marija Milovanovic et al.
IMMUNOLOGIC RESEARCH (2012)
CREM overexpression decreases IL-2 production, induces a TH17 phenotype and accelerates autoimmunity
Ralph Lippe et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats
Kenro Miyasato et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
IL-2-Controlled Expression of Multiple T Cell Trafficking Genes and Th2 Cytokines in the Regulatory T Cell-Deficient Scurfy Mice: Implication to Multiorgan Inflammation and Control of Skin and Lung Inflammation
Rahul Sharma et al.
JOURNAL OF IMMUNOLOGY (2011)
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α-Mediated Bone Loss
Mario M. Zaiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Robert M. Anthony et al.
NATURE (2011)
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
Xiang-Ping Yang et al.
NATURE IMMUNOLOGY (2011)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cutting Edge: Mechanisms of IL-2-Dependent Maintenance of Functional Regulatory T Cells
Luke Barron et al.
JOURNAL OF IMMUNOLOGY (2010)
Access to Care and the Incidence of Endstage Renal Disease Due to Systemic Lupus Erythematosus
Michael M. Ward
JOURNAL OF RHEUMATOLOGY (2010)
The role of defective clearance of apoptotic cells in systemic autoimmunity
Luis E. Munoz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury
N. Mato et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Excessive production of IFN-γ in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B
Masayoshi Harigai et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4(+)Foxp3(+) regulatory T cell development
Kieng B. Vang et al.
JOURNAL OF IMMUNOLOGY (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
Agonistic Anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining foxp3 expression
P. Zhang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus
Hye-Young Chun et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors
JF Zhu et al.
CELL RESEARCH (2006)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets
HK Kang et al.
JOURNAL OF IMMUNOLOGY (2005)
Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells
I Takeda et al.
JOURNAL OF IMMUNOLOGY (2004)
分享论文
